• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

LPTN:US

3.7300 USD 0.1100 2.86%

As of 20:10:00 ET on 07/25/2014.

Snapshot for Lpath Inc (LPTN)

Open: 3.8500 Day's Range: 3.7000 - 3.8500 Volume: 32,934
Previous Close: 3.8400 52wk Range: 3.2500 - 6.7000 1-Yr Rtn: -17.48%

Stock Chart for LPTN

No chart data available.
  • LPTN:US 3.7000
  • 1D
  • 1M
  • 1Y
3.8400
Interactive LPTN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LPTN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6594
Est. EPS (USD) (12/2014) -0.6700
Est. PEG Ratio -
Market Cap (M USD) 58.15
Shares Outstanding (M) 15.59
30 Day Average Volume 33,993
Price/Book (mrq) 3.7139
Price/Sale (ttm) 5.9245
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LPTN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LPTN

Lpath, Inc. is a drug discovery company with a focus on bioactive signaling lipids as targets for treating and diagnosing human diseases.

Scott R PancoastPresident/CEOGary J G AtkinsonSenior VP/CFO/Secretary
Dario A PaggiarinoSenior VP/Chief Dev OfcrGary WoodnuttSenior VP:Research & Dev
More Company Profile & Key Executives for LPTN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil